Arvinas ARVN
NASDAQ ARVN
$9.35 +0.04 (+0.43%)
As of: Sep 4, 2026 · 2:27 PM EDT

Arvinas (ARVN) Other Working Capital Changes (2017 - 2026)

Arvinas (ARVN) posted quarterly Other Working Capital Changes of -$15.6 million for Q1 2026, down 3020.0% year-over-year from $534246.6 in Q1 2025, and up 93.53% quarter-over-quarter from -$241.0 million in Q4 2025.

Analysis

Arvinas (ARVN) Other Working Capital Changes (2017 - 2026) Analysis & Trends

Arvinas' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$15.6 million for Q1 2026.

  • In Q1 2026, Other Working Capital Changes fell 3020.0% year-over-year to -$15.6 million; the TTM figure through Mar 2026 stood at -$257.7 million (down 155.15% YoY), while the FY2025 annual figure was -$242.6 million, down 140.2% from the prior year.
  • Other Working Capital Changes for Q1 2026 stood at -$15.6 million, up from -$241.0 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $4.1 million in Q2 2024, with the low at -$6.9 million in Q1 2023.
  • The 5-year median for Other Working Capital Changes is $400000.0 (2024), against an average of -$588235.3.
  • The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes sank 18175.0% in 2023, then surged 10200.0% in 2024.
  • Arvinas' Other Working Capital Changes stood at -$400000.0 in 2022, then tumbled by 18175.0% to -$73.1 million in 2023, then plunged by 35.98% to -$99.4 million in 2024, then sank by 142.45% to -$241.0 million in 2025, then jumped by 93.53% to -$15.6 million in 2026.
  • Business Quant data shows ARVN's Other Working Capital Changes at -$15.6 million in Q1 2026, -$241.0 million in Q4 2025, and $209.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Arvinas 605.88 Mn 37.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -189.90 Mn
Jun 30, 2026 -189.90 Mn
Mar 31, 2026 -15.60 Mn
Mar 31, 2026 -15.60 Mn
Dec 31, 2025 -9.50 Mn
Dec 31, 2025 -9.50 Mn
Sep 30, 2025 -21.80 Mn
Sep 30, 2025 -21.80 Mn
Jun 30, 2025 -22.40 Mn
Jun 30, 2025 -22.40 Mn
Mar 31, 2025 -188.90 Mn
Mar 31, 2025 -188.90 Mn
Dec 31, 2024 -55.50 Mn
Dec 31, 2024 -55.50 Mn
Sep 30, 2024 -95.50 Mn
Sep 30, 2024 -95.50 Mn
Jun 30, 2024 75.30 Mn
Jun 30, 2024 75.30 Mn
Mar 31, 2024 -25.30 Mn
Mar 31, 2024 -25.30 Mn